Gilead Sciences (GILD)

76.35 +0.29 (0.38%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/20 *Est.)
- M&A (6/30/20 *Est)

Latest Headlines

European Commission Grants Conditional Marketing Authorization for Gilead’s Veklury® (remdesivir) for the Treatment of COVID-19 July 3, 2020 7:56 AM - BizWire Gilead's COVID-19 antiviral remdesivir gets conditional EU clearance July 3, 2020 7:52 AM - StreetInsider Form 4 GILEAD SCIENCES INC For: Jun 29 Filed by: Whitley Richard James July 1, 2020 5:04 PM - SEC Filing Form 4 GILEAD SCIENCES INC For: Jun 29 Filed by: Lofton Kevin E July 1, 2020 4:56 PM - SEC Filing Gilead Sciences Demonstrates Commitment to Scientific Innovation In HIV With New Prevention, Treatment and Cure Research Data Presented At AIDS 2020: Virtual July 1, 2020 8:30 AM - BizWire Gilead Sciences (GILD) Attempts to 'Thread the Needle' with Remdesivir Pricing - Baird June 29, 2020 1:15 PM - StreetInsider Wall Street ends higher on Boeing bump, stimulus eyed June 29, 2020 7:11 AM - StreetInsider Gilead Sciences (GILD) says remdesivir treatment equates to $2,340 per patient June 29, 2020 7:03 AM - StreetInsider An Open Letter from Daniel O’Day, Chairman & CEO, Gilead Sciences June 29, 2020 7:00 AM - BizWire U.S. to ship remdesivir to states including California and Texas with rising COVID-19 cases June 26, 2020 2:11 PM - StreetInsider Special Report: As world approaches 10 million coronavirus cases, doctors see hope in new treatments June 26, 2020 7:15 AM - StreetInsider Form 4 GILEAD SCIENCES INC For: Jun 23 Filed by: Rodriguez Javier June 25, 2020 1:51 PM - SEC Filing Form 3/A GILEAD SCIENCES INC For: Jun 15 Filed by: Rodriguez Javier June 25, 2020 1:46 PM - SEC Filing Europe's CHMP Recommends Approval of Gilead's (GILD) Remdesivir for COVID-19 June 25, 2020 8:37 AM - StreetInsider Gilead Sciences (GILD) call put ratio 2 calls to 1 put amid rise in Covid 19 cases June 25, 2020 5:22 AM - StreetInsider Gilead Sciences (GILD) will acquire 49.9% equity interest in Pionyr Immunotherapeutic for $275 million June 23, 2020 8:32 AM - StreetInsider Gilead Sciences Secures Exclusive Option to Acquire Pionyr Immunotherapeutics June 23, 2020 8:30 AM - BizWire Gilead targets remdesivir supply for two million COVID-19 patients by year-end June 22, 2020 1:47 PM - StreetInsider Gilead Sciences (GILD) to start trials of an inhaled version of remdesivir: CEO June 22, 2020 9:08 AM - StreetInsider India gives Hetero Labs and Cipla approval to make Gilead's COVID-19 drug June 21, 2020 7:30 AM - StreetInsider U.S. hospitals in hard hit regions step up use of steroids on sickest COVID-19 patients June 19, 2020 6:05 AM - StreetInsider Gilead Sciences (GILD) to soon begin enrollment of Phase 2/3 trials of Remdesivir in about 50 pediatric COVID-19 patients - Reuters June 17, 2020 3:39 PM - StreetInsider Form 4 GILEAD SCIENCES INC For: Jun 15 Filed by: Rodriguez Javier June 16, 2020 6:52 PM - SEC Filing Form 3 GILEAD SCIENCES INC For: Jun 15 Filed by: Rodriguez Javier June 16, 2020 6:43 PM - SEC Filing Form 8-K GILEAD SCIENCES INC For: Jun 14 June 16, 2020 4:27 PM - SEC Filing Gilead Sciences (GILD) Appoints Javier Rodriguez to Board June 16, 2020 4:13 PM - StreetInsider Javier Rodriguez Joins Gilead Sciences’ Board of Directors June 16, 2020 4:05 PM - BizWire Steroid drug hailed as 'breakthrough' for seriously ill COVID-19 patients June 16, 2020 8:28 AM - StreetInsider FDA Warns Newly Discovered Potential Drug Interaction May Reduce Effectiveness of Gilead's (GILD) COVID-19 Treatment Remdesivir June 15, 2020 4:20 PM - StreetInsider Active options June 15: ZM JPM BCE GILD CCL GNUS DIS UAL FB MGM TWTR June 15, 2020 9:45 AM - StreetInsider Form 4 GILEAD SCIENCES INC For: Jun 10 Filed by: Dickinson Andrew D June 12, 2020 3:28 PM - SEC Filing Gilead Sciences (GILD) call put ratio 4.2 calls to 1 put with focus on August 120 calls June 12, 2020 2:45 PM - StreetInsider Gilead Sciences (GILD) Company, Kite, Granted European Medicines Agency Approval for CAR T Cell Therapy Manufacturing Facility in Europe June 12, 2020 8:03 AM - StreetInsider Kite Receives European Medicines Agency Approval for CAR T Cell Therapy Manufacturing Facility in Europe June 12, 2020 8:00 AM - BizWire Gilead Sciences (GILD) said to refinance $2.5B loan facility - Bloomberg June 10, 2020 1:43 PM - StreetInsider AstraZeneca (AZN) CEO Soriot Said to Have Called Gilead (GILD) CEO on May 9, Proposed Exploring Merger to O'Day on Call - Bloomberg June 8, 2020 5:04 PM - StreetInsider Gilead Sciences (GILD) Worth $120+ in Rumored Takeover - Piper Sandler June 8, 2020 9:49 AM - StreetInsider AstraZeneca (AZN) and Gilead Sciences (GILD) not in deal talks, but may have been CEO-to-CEO approach - CNBC's Faber June 8, 2020 9:17 AM - StreetInsider Gilead Sciences (GILD) Pipeline Unaffected in Potential Merger Scenario - RBC Capital June 8, 2020 7:24 AM - StreetInsider Gilead Sciences (GILD) Gains 3% on Report AstraZeneca (AZN) Approached About a Merger June 8, 2020 6:18 AM - StreetInsider Gilead Sciences (GILD) option implied flat into reports AstraZeneca (AZN) approaches June 8, 2020 4:38 AM - StreetInsider Gilead Sciences (GILD) call put ratio 33 calls to 1 put into approaches Gilead (GILD) about potential merger, Bloomberg says June 8, 2020 4:34 AM - StreetInsider European stocks take a breather as tech, healthcare weigh June 8, 2020 3:32 AM - StreetInsider AstraZeneca, Gilead merger doubted by Wall Street analysts June 8, 2020 3:20 AM - StreetInsider AstraZeneca contacted Gilead over potential megamerger: Bloomberg News June 7, 2020 4:21 AM - StreetInsider Gilead Sciences (GILD), Galapagos (GLPG) announce new analyses from two clinical trials evaluating filgotinib in adults with PsA June 5, 2020 4:02 PM - StreetInsider New Analyses of Phase 2 EQUATOR Clinical Program Support Durable Efficacy of Filgotinib in Psoriatic Arthritis June 5, 2020 4:01 PM - BizWire NEW ANALYSES OF PHASE 2 EQUATOR CLINICAL PROGRAM SUPPORT DURABLE EFFICACY OF FILGOTINIB IN PSORIATIC ARTHRITIS June 5, 2020 4:01 PM - StreetInsider Chinese and Iranian hackers targeted Biden and Trump campaigns, Google says June 4, 2020 1:10 PM - StreetInsider Gilead Sciences (GILD), Galapagos NV (GLPG) Report Filgotinib Demonstrates Durable Efficacy & Consistent Safety Profile at 52-Weeks in FINCH 1 and 3 Studies in Rheumatoid Arthritis June 4, 2020 6:09 AM - StreetInsider Filgotinib Demonstrates Durable Efficacy and Consistent Safety Profile at 52 Weeks in FINCH 1 and 3 Studies in Rheumatoid Arthritis June 4, 2020 1:29 AM - BizWire FILGOTINIB DEMONSTRATES DURABLE EFFICACY AND CONSISTENT SAFETY PROFILE AT 52 WEEKS IN FINCH 1 AND 3 STUDIES IN RHEUMATOID ARTHRITIS June 4, 2020 1:00 AM - StreetInsider Gilead's remdesivir could see $7 billion in annual sales on stockpiling boost: analyst June 3, 2020 12:25 PM - StreetInsider UPDATE: SVB Leerink Upgrades Gilead Sciences (GILD) to Outperform June 3, 2020 7:18 AM - StreetInsider Gilead Sciences (GILD) Reimbursement Experts Confirm HIV Market Opportunity is Well Insulated - RBC Capital June 3, 2020 6:29 AM - StreetInsider Gilead Sciences (GILD) PT Lowered to $82 at BofA Securities June 2, 2020 10:04 AM - StreetInsider Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions June 2, 2020 7:10 AM - StreetInsider Mark Genovese Joins Gilead to Lead Clinical Development of Company’s Inflammation Programs June 1, 2020 4:05 PM - BizWire Gilead's remdesivir shows modest improvement in moderate COVID-19 patients June 1, 2020 2:57 PM - StreetInsider Pre-Open Movers 06/01: (PTI) (COTY) (AAXN) Higher; (NVUS) (PFE) (GILD) Lower (more...) June 1, 2020 9:27 AM - StreetInsider Gilead Sciences (GILD) option implied volatility into Remdesivir Moderate COVID-19 Study June 1, 2020 8:37 AM - StreetInsider Wall Street closes higher as recovery signs soothe protest, pandemic worries June 1, 2020 8:34 AM - StreetInsider Gilead Sciences (GILD) Remdesivir Moderate COVID-19 Study Shows 65% More Likely to have Clinical Improvement at Day 11 June 1, 2020 8:33 AM - StreetInsider Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19 June 1, 2020 8:30 AM - BizWire Gilead trades that made millions on COVID-19 drug news raise eyebrows June 1, 2020 7:07 AM - StreetInsider Exclusive: Russia to roll out its first approved COVID-19 drug next week June 1, 2020 2:33 AM - StreetInsider Scientists hunt pandemic hotspots in race to test vaccines June 1, 2020 2:03 AM - StreetInsider European, South Korean authorities vie for COVID-19 antiviral remdesivir May 29, 2020 12:53 PM - StreetInsider Gilead Sciences (GILD) calls more active than puts into ASCO20 Virtual May 29, 2020 10:27 AM - StreetInsider Gilead Sciences (GILD) Announces Yescarta Demonstrates High Rates of Response in Relapsed or Refractory Indolent Non-Hodgkin Lymphoma May 29, 2020 8:02 AM - StreetInsider Gilead Sciences (GILD) Announces Investigational Magrolimab in Combination With Azacitidine Demonstrates Durable Activity in Previously-Untreated Myelodysplastic Syndrome and AML May 29, 2020 8:02 AM - StreetInsider Yescarta® (Axicabtagene Ciloleucel) Demonstrates High Rates of Response in Relapsed or Refractory Indolent Non-Hodgkin Lymphoma May 29, 2020 8:00 AM - BizWire Investigational Magrolimab in Combination With Azacitidine Demonstrates Durable Activity in Previously-Untreated Myelodysplastic Syndrome and Acute Myeloid Leukemia May 29, 2020 8:00 AM - BizWire Gilead study shows shorter five-day course of remdesivir works as well as 10-day one May 27, 2020 4:58 PM - StreetInsider Gilead Sciences (GILD), Arcus Biosciences (RCUS) Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies May 27, 2020 7:12 AM - StreetInsider Gilead Sciences and Arcus Biosciences Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies May 27, 2020 7:11 AM - BizWire Merck to buy Austrian vaccine maker as it jumps into COVID-19 race May 26, 2020 9:51 AM - StreetInsider UPDATE: SunTrust Upgrades Gilead Sciences (GILD) to Hold; 'More clarity on commercial model forremdesivir' May 26, 2020 6:09 AM - StreetInsider NIH trial: Gilead's drug works best in COVID patients on oxygen May 22, 2020 8:13 PM - StreetInsider U.S. doctors call for remdesivir data to guide coronavirus treatment May 21, 2020 5:15 PM - StreetInsider Gilead (GILD) New Drug Filgotinib is Relatively Safe, But Black Box Still Likely - Baird May 21, 2020 9:37 AM - StreetInsider Pre-Open Stock Movers 05/21: (ACB) (KDMN) (TJX) Higher; (SCPH) (RUTH) (FLXN) Lower (more...) May 21, 2020 9:27 AM - StreetInsider Higher dose of Gilead-Galapagos drug meets ulcerative colitis study goals May 20, 2020 7:33 PM - StreetInsider Form 4 GILEAD SCIENCES INC For: Nov 27 Filed by: Lofton Kevin E May 20, 2020 7:14 PM - SEC Filing After-Hours Movers 05/20: (ACB) (SCVL) (EXPE) Higher; (SCPH) (GLPG) (FLXN) Lower (more...) May 20, 2020 6:07 PM - StreetInsider Form S-8 GILEAD SCIENCES INC May 20, 2020 4:03 PM - SEC Filing Gilead Sciences (GILD), Galapagos NV (GLPG) Phase 2B/3 Trial of Filgotinib Met All Primary Endpoints May 20, 2020 4:03 PM - StreetInsider Gilead and Galapagos Announce Positive Topline Results of Phase 2b/3 Trial of Filgotinib in Moderately to Severely Active Ulcerative Colitis May 20, 2020 4:03 PM - BizWire GILEAD AND GALAPAGOS ANNOUNCE POSITIVE TOPLINE RESULTS OF PHASE 2B/3 TRIAL OF FILGOTINIB IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS May 20, 2020 4:01 PM - StreetInsider Gilead Sciences (GILD) Could Have Commercial Remdesivir Revenue is Q3/Q4 - SunTrust May 18, 2020 5:31 PM - StreetInsider Gilead and Kite Continue to Advance Next Generation Cancer Therapies at 2020 American Society of Clinical Oncology Annual Meeting May 13, 2020 5:00 PM - BizWire Gilead's (GILD) Remdesivir is 'The Drug You Want Your Parents to Take' - Piper citing KOL May 13, 2020 1:54 PM - StreetInsider Gilead (GILD) signs licensing agreements with five generic pharmaceutical manufacturers based in India and Pakistan to further expand supply of remdesivir May 12, 2020 2:02 PM - StreetInsider EMA Recommends Expanding Gilead (GILD) Remdesivir Compassionate Use to Patients Not on Mechanical Ventilator, Additional Treatment Duration Introduced - Reuters May 11, 2020 3:01 PM - StreetInsider Gilead Sciences (GILD) Remdesivir in Shorter Supply than the Base Case Implies - RBC Capital May 11, 2020 6:45 AM - StreetInsider Gilead Sciences (GILD) call put ratio ratio 2.5 calls to 1 put May 8, 2020 3:03 PM - StreetInsider Exclusive: Iran-linked hackers recently targeted coronavirus drugmaker Gilead - sources May 8, 2020 1:20 PM - StreetInsider Hackers linked to Iran have targeted Gilead Sciences (GILD) staff in recent weeks - Reuters May 8, 2020 1:19 PM - StreetInsider Form 8-K GILEAD SCIENCES INC For: May 06 May 8, 2020 12:55 PM - SEC Filing Form 4 GILEAD SCIENCES INC For: May 05 Filed by: MANWANI HARISH May 7, 2020 8:37 PM - SEC Filing Form 4 GILEAD SCIENCES INC For: May 05 Filed by: Whitley Richard James May 7, 2020 8:31 PM - SEC Filing Form 4 GILEAD SCIENCES INC For: May 05 Filed by: WOLD OLSEN PER May 7, 2020 8:27 PM - SEC Filing Form 4 GILEAD SCIENCES INC For: May 05 Filed by: Lofton Kevin E May 7, 2020 8:21 PM - SEC Filing Form 4 GILEAD SCIENCES INC For: May 06 Filed by: BARTON JACQUELINE K May 7, 2020 8:09 PM - SEC Filing Form 4 GILEAD SCIENCES INC For: May 06 Filed by: Kramer Kelly A. May 7, 2020 7:50 PM - SEC Filing Form 4 GILEAD SCIENCES INC For: May 06 Filed by: Horning Sandra May 7, 2020 7:40 PM - SEC Filing Form 4 GILEAD SCIENCES INC For: May 05 Filed by: WILSON GAYLE E May 7, 2020 7:17 PM - SEC Filing Form 4 GILEAD SCIENCES INC For: May 05 Filed by: Pletcher Brett A May 7, 2020 6:02 PM - SEC Filing Gilead Sciences (GILD) Confirms Approval of Remdesivir in Japan for Patients With Severe COVID-19 May 7, 2020 11:46 AM - StreetInsider Gilead Announces Approval of Veklury® (remdesivir) in Japan for Patients With Severe COVID-19 May 7, 2020 11:45 AM - BizWire Gilead Sciences (GILD) remdesivir approved in Japan to treat COVID-19 - Reuters May 7, 2020 7:53 AM - StreetInsider Form 4 GILEAD SCIENCES INC For: May 04 Filed by: Wilfong Diane E. May 6, 2020 6:40 PM - SEC Filing Will Gilead price its coronavirus drug for public good or company profit? May 6, 2020 1:42 PM - StreetInsider Form 10-Q GILEAD SCIENCES INC For: Mar 31 May 6, 2020 6:03 AM - SEC Filing Gilead (GILD) says it's working to further accelerate and maximize global supply of Remdesivir May 5, 2020 5:24 PM - StreetInsider Form 4 GILEAD SCIENCES INC For: May 04 Filed by: Cogan John Francis May 5, 2020 4:29 PM - SEC Filing Gilead Sciences (GILD) remdesiver may be approved in Japan on Thursday - Reuters citing health minster May 5, 2020 12:24 PM - StreetInsider Gilead Sciences (GILD) Likely to Provide Remdesivir to only 1/3 of US Patients - RBC Capital May 5, 2020 7:18 AM - StreetInsider Who expert said 'there are signals of hope' for the potential use of Gilead Sciences (GILD) remdisivir - Reuters May 4, 2020 1:16 PM - StreetInsider Gilead Sciences (GILD) IV at lower end of five-week range May 4, 2020 5:12 AM - StreetInsider Active options: GILD NFLX X GILD CCL DAL BABA GE ZM C F SNAP May 4, 2020 4:37 AM - StreetInsider Gilead (GILD) sets goal of producing at least 500,000 treatment courses of remdesivir by October May 1, 2020 4:21 PM - StreetInsider Gilead’s Investigational Antiviral Remdesivir Receives U.S. Food and Drug Administration Emergency Use Authorization for the Treatment of COVID-19 May 1, 2020 4:19 PM - BizWire U.S. emergency approval broadens use of Gilead's COVID-19 drug remdesivir May 1, 2020 4:18 PM - StreetInsider FDA Confirms it Issued Emergency Use Authorization for Gilead's (GILD) Remdesivir as Potential COVID-19 Treatment May 1, 2020 4:13 PM - StreetInsider Gilead Sciences' (GILD) Remdesivir Receives FDA Emergency Use Authorization For COVID-19 May 1, 2020 3:51 PM - StreetInsider Gilead Sciences (GILD) IV flat, Trump Says FDA Has Approved Gilead Virus Drug for Emergency Use – Bloomberg May 1, 2020 3:49 PM - StreetInsider Trump Says FDA Has Approved Gilead (GILD) Virus Drug for Emergency Use - Bloomberg May 1, 2020 3:40 PM - StreetInsider Active options: NFLX X GILD CCL DAL BABA GE ZM C F SNAP May 1, 2020 2:56 PM - StreetInsider Gilead Sciences (GILD) PT Raised to $77 at Morgan Stanley May 1, 2020 9:28 AM - StreetInsider Pre-Open Stock Movers 05/01: (MRNA) (CLX) (WHR) Higher; (CURO) (WDC) (FLR) (AMZN) Lower (more...) May 1, 2020 9:21 AM - StreetInsider Gilead Sciences (GILD) PT Raised to $90 at Oppenheimer May 1, 2020 8:12 AM - StreetInsider Gilead Sciences (GILD) PT Raised to $88 at RBC Capital May 1, 2020 6:22 AM - StreetInsider Gilead Sciences (GILD) PT Raised to $67 at Barclays May 1, 2020 6:07 AM - StreetInsider JPMorgan Downgrades Gilead Sciences (GILD) to Neutral May 1, 2020 5:36 AM - StreetInsider Gilead Sciences (GILD) PT Raised to $97 at Jefferies May 1, 2020 4:49 AM - StreetInsider SunTrust Downgrades Gilead Sciences (GILD) to Sell May 1, 2020 4:25 AM - StreetInsider Gilead Sciences (GILD) PT Raised to $75 at Bernstein May 1, 2020 4:25 AM - StreetInsider UPDATE: Raymond James Downgrades Gilead Sciences (GILD) to Market Perform May 1, 2020 4:25 AM - StreetInsider After-Hours Stock Movers 04/30: (INT) (RMD) (FND) Higher; (WDC) (ZEN) (AMZN) (AAPL) Lower (more...) April 30, 2020 5:59 PM - StreetInsider Gilead Sciences (GILD) Declares $0.68 Quarterly Dividend; 3.3% Yield April 30, 2020 5:21 PM - StreetInsider Gilead to work with partners to ramp up production of potential coronavirus treatment April 30, 2020 4:32 PM - StreetInsider Form 8-K GILEAD SCIENCES INC For: Apr 30 April 30, 2020 4:09 PM - SEC Filing Gilead Sciences (GILD) Tops Q1 EPS by 11c April 30, 2020 4:07 PM - StreetInsider Gilead Sciences Announces Second Quarter 2020 Dividend April 30, 2020 4:02 PM - BizWire Gilead Sciences Announces First Quarter 2020 Financial Results April 30, 2020 4:01 PM - BizWire Gilead Sciences (GILD) weekly IV at 116 into EPS, outlook and pipeline outlook April 30, 2020 3:43 PM - StreetInsider FDA Head Says Moving at Lightning Speed on Gilead (GILD) Virus Drug, Declines to Offer Timeline for Remdesivir Review - Bloomberg April 30, 2020 9:19 AM - StreetInsider Glenmark to conduct trials in India for potential COVID-19 drug April 30, 2020 12:35 AM - StreetInsider Global equities dip at end of best month since '09 April 29, 2020 7:37 PM - StreetInsider Form 4 GILEAD SCIENCES INC For: Apr 27 Filed by: Cogan John Francis April 29, 2020 7:28 PM - SEC Filing Gilead Sciences (GILD) calls active after positive remdesivir results April 29, 2020 4:10 PM - StreetInsider Gilead Sciences (GILD) IV at 100 after positive remdesivir results April 29, 2020 3:35 PM - StreetInsider FDA Emergency Use Approval of Gilead's (GILD) Remdesiver Planned as Soon as Wednesday - NYT April 29, 2020 2:23 PM - StreetInsider NIH Clinical Trial Shows Gilead's (GILD) Remdesivir Accelerates Recovery from Advanced COVID-19 April 29, 2020 2:14 PM - StreetInsider SunTrust Weighs in Dr. Fauci's Summary of NIAID Data on Gilead (GILD) Remdesivir April 29, 2020 1:37 PM - StreetInsider Despite 'Crazy Data Points' Gilead's (GILD) Remdesivir Could Be Approved as Soon as Today - Baird April 29, 2020 1:16 PM - StreetInsider Gilead Sciences (GILD) Pushes to Session Highs; Up 8% April 29, 2020 12:53 PM - StreetInsider Fauci Says Data Shows Gilead's (GILD) Remdesivir has Clear Cut Positive Effect on Virus - Bloomberg April 29, 2020 11:55 AM - StreetInsider Raymond James Said 'Let's Not Overreact' to Today's Gilead Sciences (GILD) Data April 29, 2020 11:47 AM - StreetInsider Gilead (GILD) Rembesivir Failed in First Clinical Trial From China, Study Published in Lancet - Reports April 29, 2020 11:17 AM - StreetInsider Gilead Sciences (GILD) call put ratio 3 calls to 1 put into quarter results April 29, 2020 10:52 AM - StreetInsider U.S. NIH to Release Gilead (GILD) Virus Drug Trial Results Later Today, Likely to be Released at White House Event - Bloomberg April 29, 2020 10:51 AM - StreetInsider FDA in Talks to Make Remdesivir Available as Appropriate, Agency Talking with Gilead (GILD) to Get Drug to Patients Quickly - Bloomberg, Citing Email April 29, 2020 10:15 AM - StreetInsider Florida moves to ease coronavirus lockdown as promising treatment emerges April 29, 2020 10:08 AM - StreetInsider Gilead Sciences (GILD) gains 8% as trading resumes April 29, 2020 9:00 AM - StreetInsider Data on Gilead drug raises hopes in pandemic fight, Fauci calls it 'highly significant' April 29, 2020 8:54 AM - StreetInsider Gilead Sciences (GILD) to resume trading at 9:00AM ET April 29, 2020 8:40 AM - StreetInsider Gilead Sciences (GILD) Phase 3 Trial of Remdesivir in Severe COVID-19 Patients Shows Improvement April 29, 2020 8:38 AM - StreetInsider Gilead Sciences (GILD) IV at 73 into positive remdesivir results April 29, 2020 8:38 AM - StreetInsider Stock futures add to gains amid positive Gilead remdesivir results April 29, 2020 8:35 AM - StreetInsider Gilead Announces Results From Phase 3 Trial of Investigational Antiviral Remdesivir in Patients With Severe COVID-19 April 29, 2020 8:35 AM - BizWire Gilead (GILD) Says NIAID Study of Investigational Antiviral Remdesivir for COVID-19 Met Its Primary Endpoint April 29, 2020 8:30 AM - StreetInsider Gilead Sciences Statement on Positive Data Emerging From National Institute of Allergy and Infectious Diseases’ Study of Investigational Antiviral Remdesivir for COVID-19 April 29, 2020 8:30 AM - BizWire Gilead Sciences (GILD) Halted, News Pending April 29, 2020 8:25 AM - StreetInsider Wall Street rallies on promising coronavirus drug April 29, 2020 6:51 AM - StreetInsider European shares rise on COVID-19 drug hopes, upbeat outlook from corporates April 29, 2020 5:10 AM - StreetInsider Dollar drops as Fed repeats vow to support economy April 28, 2020 9:03 PM - StreetInsider Shares jump on coronavirus treatment hopes, oil soars April 28, 2020 8:18 PM - StreetInsider Gilead Sciences (GILD) Gains as Potential Japanese Remdesivir Approval Weighed Against UBS Downgrade April 27, 2020 9:33 AM - StreetInsider Gilead Sciences (GILD) Clarifies Remdesivir Data - RBC Capital April 27, 2020 7:57 AM - StreetInsider UBS Downgrades Gilead Sciences (GILD) to Neutral; Balanced Risk/Reward Into Remdesivir Readout April 27, 2020 4:48 AM - StreetInsider Investors bet on testing, treatments for restart of U.S. economy April 26, 2020 8:57 PM - StreetInsider UPDATE: U.S. gov trial of Gilead Sciences (GILD) COVID drug running ahead of schedule - Reuters April 24, 2020 1:32 PM - StreetInsider Active options April 24, 2020 4:20 AM - StreetInsider WHO China Data Likely to Drive View that Gilead (GILD) Remdesivir Isn't Working in Severe Patients - Raymond James April 23, 2020 2:00 PM - StreetInsider Gilead Sciences (GILD) China Trial Results 'In Line with our Expectations' - RBC April 23, 2020 1:40 PM - StreetInsider Gilead Sciences (GILD) Remdesivir China Results 'Very Sobering' - Baird April 23, 2020 1:34 PM - StreetInsider SunTrust Said Need to See Gilead Sciences (GILD) Controlled Data on Remdesivir April 23, 2020 1:32 PM - StreetInsider Gilead Sciences (GILD) call put ratio 2.3 calls to 1 put after FT says remdesivir failed in first trial April 23, 2020 1:03 PM - StreetInsider Gilead Sciences (GILD) said post included inappropriate characterization of the study - STAT, citing Spokesperson April 23, 2020 12:56 PM - StreetInsider Gilead Sciences (GILD) Resumes; Shares Down 2.5% April 23, 2020 12:53 PM - StreetInsider Gilead Sciences (GILD) call put ratio 1 call to 1 put, FT says remdesivir failed in first trial April 23, 2020 12:51 PM - StreetInsider Gilead Sciences (GILD) Halted on LUDP April 23, 2020 12:46 PM - StreetInsider Gilead Sciences' (GILD) Antiviral Drug Remdesivir Flops in First trial - FT April 23, 2020 12:45 PM - StreetInsider Gilead Sciences (GILD) April weeky calls active on open April 23, 2020 9:34 AM - StreetInsider S&P 500 slips after report on coronavirus drug trial April 23, 2020 7:12 AM - StreetInsider RBC Capital Handicaps Gilead Sciences (GILD) Upcoming Remdesivir Data April 23, 2020 6:14 AM - StreetInsider Form 4 GILEAD SCIENCES INC For: Apr 20 Filed by: Cogan John Francis April 21, 2020 7:42 PM - SEC Filing Gilead (GILD), Kite and oNKo-innate Announce Research Collaboration to Discover Cancer Immunotherapies April 21, 2020 4:17 PM - StreetInsider Gilead, Kite and oNKo-innate Announce Research Collaboration to Discover Cancer Immunotherapies Focused on Natural Killer (NK) Cells April 21, 2020 4:15 PM - BizWire Gilead Sciences (GILD) PT Raised to $64 at Credit Suisse April 21, 2020 6:23 AM - StreetInsider Wells Fargo Downgrades Gilead Sciences (GILD) to Equal Weight April 20, 2020 4:28 AM - StreetInsider BMO Capital Downgrades Gilead Sciences (GILD) to Market Perform; Risk/Reward Unfavorable April 20, 2020 4:28 AM - StreetInsider Stock market gains alongside economic pain; some worry about over-optimism April 19, 2020 12:04 PM - StreetInsider Gilead Sciences (GILD) on Watch Amid STAT Webcast April 17, 2020 1:10 PM - StreetInsider CFRA Downgrades Gilead Sciences (GILD) to Sell April 17, 2020 11:30 AM - StreetInsider Gilead Sciences (GILD) calls more active than puts as shares rally 8% on remdesivir COVID-19 trial April 17, 2020 11:26 AM - StreetInsider Gilead Sciences (GILD) call put ratio 1.8 calls to 1 put after report on remdesivir COVID-19 trial April 17, 2020 9:55 AM - StreetInsider Active options: GILD AAPL BAC BA MSFT TSLA AMD AMZN April 17, 2020 9:42 AM - StreetInsider Pre-Open Movers 04/17: (AMC) (TROX) (MRNA) Higher; (CUTR) (NLS) (CHWY) Lower (more...) April 17, 2020 9:20 AM - StreetInsider Institutional investors tell Big Pharma to cooperate on coronavirus April 17, 2020 8:41 AM - StreetInsider Gilead Sciences (GILD) Remdesivir Data Looks Encouraging, But Many Unknowns Remain - RBC Capital April 17, 2020 7:48 AM - StreetInsider Gilead Sciences (GILD) Jumps 19% on Hearsay - Raymond James April 17, 2020 7:18 AM - StreetInsider Wall Street gains on Boeing surge and coronavirus drug hopes April 17, 2020 6:24 AM - StreetInsider Gilead Sciences (GILD) Data is Encouraging but Needs a Control Arm, Credit Suisse Reiterates Underperform April 17, 2020 6:16 AM - StreetInsider Gilead Sciences (GILD) Data Amounts to Leaked Case Reports, Baird Reiterates Neutral April 17, 2020 6:12 AM - StreetInsider Options expected to have increasing volume: GILD IWM RUT SPY QQQ STT BK SLB April 17, 2020 5:00 AM - StreetInsider Options expected to have increasing volume: GILD REGN JNJ STT BK April 17, 2020 4:50 AM - StreetInsider Gilead Sciences (GILD) calls active shares up in premarket after coronavirus drug suggests patients are responding to treatment – STAT April 17, 2020 4:36 AM - StreetInsider European shares gather steam on Trump's restart plan April 17, 2020 2:13 AM - StreetInsider Stocks rally as investors take heart on U.S. economic reopening plan April 16, 2020 7:39 PM - StreetInsider After-Hours Movers 04/16: (GILD) (PLNT) (AMC) Higher; (CUTR) (NLS) (PTON) Lower (more...) April 16, 2020 6:13 PM - StreetInsider Gilead Sciences to Release First Quarter 2020 Financial Results on Thursday, April 30, 2020 April 16, 2020 5:30 PM - BizWire Gilead Sciences (GILD) IV at 62 into coronavirus drug suggests patients are responding to treatment – STAT April 16, 2020 4:38 PM - StreetInsider Early peek at data on Gilead's (GILD) coronavirus drug suggests patients are responding to treatment - STAT April 16, 2020 4:19 PM - StreetInsider Call Buying Activity in Gilead Sciences (GILD) Highlights Bullish Sentiment in Shares Through August -Susquehanna April 16, 2020 3:12 PM - StreetInsider Pre-Open Stock Movers 04/16: (RCUS) (LOVE) (BBBY) Higher; (DO) (RAD) (ATHX) Lower (more...) April 16, 2020 9:19 AM - StreetInsider Futures jump late following data on potential virus treatment, Trump guidelines April 16, 2020 6:26 AM - StreetInsider After-Hours Stock Movers 04/15: (RCUS) (AM) (BBBY) Higher; (ATHX) (CALA) (LAKE) Lower (more...) April 15, 2020 6:03 PM - StreetInsider Form DEFA14A GILEAD SCIENCES INC April 15, 2020 5:31 PM - SEC Filing Gilead Provides Additional Information Regarding 2020 Annual Meeting of Stockholders Due to COVID-19 Precautions April 15, 2020 4:15 PM - BizWire Gilead (GILD) Said to Hold Talks to Buy Stake in Arcus Biosciences (RCUS) - Bloomberg April 15, 2020 4:11 PM - StreetInsider Gilead Sciences (GILD) China/remdesivir study in mild-moderate COVID-19 patients suspended on poor enrollment - RBC April 15, 2020 8:56 AM - StreetInsider Second Covid-19 Trial of Gilead's (GILD) Remdesiver in China Suspended on Lack of Eligible Patients - Bloomberg, Citing Gov. Site April 15, 2020 8:55 AM - StreetInsider Form 4 GILEAD SCIENCES INC For: Apr 13 Filed by: Cogan John Francis April 14, 2020 3:52 PM - SEC Filing Gilead Sciences (GILD) call put ratio 3.9 calls to 1 put as shares rally 3% April 14, 2020 1:56 PM - StreetInsider Gilead Sciences (GILD) Ticks Higher as Trump Pumps Remdesivir April 14, 2020 1:03 PM - StreetInsider Form CT ORDER GILEAD SCIENCES INC April 14, 2020 9:59 AM - SEC Filing Form CT ORDER GILEAD SCIENCES INC April 14, 2020 9:57 AM - SEC Filing Form CT ORDER GILEAD SCIENCES INC April 14, 2020 9:55 AM - SEC Filing Pre-Open Movers 04/13: (BCRX) (CTSO) (ATHX) Higher; (AMC) (RCL) (CCL) Lower (more...) April 13, 2020 9:31 AM - StreetInsider Gilead Sciences (GILD) Remdesivir Data is Encouraging - Cowen April 13, 2020 6:54 AM - StreetInsider Gilead Sciences (GILD) Data Points are a Positive but An Entry Point may be Coming - Jefferies April 13, 2020 6:27 AM - StreetInsider Gilead Sciences (GILD) Compassionate Use Remdesivir Data Is an Incremental Positive - BMO Capital April 13, 2020 6:10 AM - StreetInsider Gilead Sciences (GILD) call put ratio 2.9 calls to 1 put into remdesivir improved 68% of COVID-19 patients in 53 person study April 13, 2020 4:54 AM - StreetInsider Gilead Sciences (GILD) IV into Gilead says remdesivir improved 68% of COVID-19 patients in 53 person study April 12, 2020 2:10 PM - StreetInsider Gilead Sciences (GILD) Remdesivir Study Shows Two-Third of Severe COVID-19 Patients Improved April 11, 2020 10:48 AM - StreetInsider Data on 53 Patients Treated With Investigational Antiviral Remdesivir Through the Compassionate Use Program Published in New England Journal of Medicine April 10, 2020 3:31 PM - BizWire Coronavirus drug hopefuls are cheap to make but may be in short supply April 10, 2020 8:12 AM - StreetInsider Gilead Sciences (GILD) Remdesivir COVID-19 Trial Changes Suggest Magnitude of Benefit Likely to be 'Modest' - RBC April 8, 2020 1:11 PM - StreetInsider Gilead Announces $20 Million Philanthropic Fund to Support Nonprofit Organizations Impacted by the COVID-19 Crisis April 8, 2020 1:09 PM - BizWire Gilead Sciences (GILD) call put ratio 3.5 calls to 1 put April 8, 2020 1:08 PM - StreetInsider Gilead Sciences (GILD) Has Upside to $82, Downside to $55 on Upcoming Remdesivir COVID-19 Data - SunTrust April 8, 2020 9:40 AM - StreetInsider Wall Street volatility raises fears of another selloff April 7, 2020 5:51 PM - StreetInsider Investors await data on coronavirus drugs as market rally builds April 7, 2020 3:41 PM - StreetInsider Gilead Sciences (GILD) Completes Forty Seven (FTSV) Acquisition April 7, 2020 8:32 AM - StreetInsider Gilead Completes Acquisition of Forty Seven, Inc. April 7, 2020 8:32 AM - BizWire Gilead Sciences (GILD) PT Raised to $86 at Cantor Fitzgerald April 7, 2020 6:34 AM - StreetInsider Stocks with Implied Volatility Movement April 7, 2020 4:09 AM - StreetInsider Gilead Sciences (GILD) calls active, shares down 2.2% April 6, 2020 11:01 AM - StreetInsider Gilead Sciences (GILD) CEO Provides Remdesivir COVID-19 Update; Providing Current 140K Courses at No Cost, Sees Additional 1M Courses by Year-End April 6, 2020 7:05 AM - StreetInsider Gilead Sciences (GILD) Long Term Picture Still Uncertain, Credit Suisse Reiterates Underperform April 6, 2020 6:45 AM - StreetInsider Gilead Sciences (GILD) Ramping Production, Jefferies Reiterates Buy April 6, 2020 6:34 AM - StreetInsider Gilead Sciences (GILD) and Second Genome Announce Agreement in Biomarker and Inflammatory Bowel Disease Drug Discovery April 6, 2020 6:16 AM - StreetInsider Gilead Sciences and Second Genome Announce Strategic Collaboration in Biomarker and Inflammatory Bowel Disease Drug Discovery April 6, 2020 6:15 AM - BizWire Gilead Sciences (GILD) IV at 77, below 52-week high of 108 April 6, 2020 4:25 AM - StreetInsider Popular stocks with increasing unusual: UBER LK GILD CCL OXY April 6, 2020 4:13 AM - StreetInsider Full Article List